BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 1973548)

  • 1. Neuroleptic malignant syndrome with renal and respiratory complications--a case report.
    Liam CK; Ong SB
    Singapore Med J; 1990 Apr; 31(2):182-4. PubMed ID: 1973548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state.
    Rock W; Elias M; Lev A; Saliba WR
    Am J Emerg Med; 2009 Oct; 27(8):1018.e1-3. PubMed ID: 19857430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe hyponatremia, neuroleptic malignant syndrome, rhabdomyolysis and acute renal failure: a case report.
    Elizalde-Sciavolino C; Racco A; Proscia-Lieto T; Kleiner M
    Mt Sinai J Med; 1998 Sep; 65(4):284-8. PubMed ID: 9757749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Polytrauma and malignant neuroleptic syndrome. Case presentation with diagnostic problems].
    Röther J; Jakob J; Bender HJ; Hewer W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1995 Nov; 30(7):455-7. PubMed ID: 8562725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rhabdomyolysis and acute renal failure caused by haloperidol-decanoate (neuroleptic malignant syndrome)].
    Lazzarin M; Benati F; Cesario V
    Recenti Prog Med; 1996 Sep; 87(9):422-4. PubMed ID: 9053957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fulminant case of neuroleptic malignant syndrome.
    Teo SK; Lam KN; Chew WL
    Singapore Med J; 1994 Feb; 35(1):110-1. PubMed ID: 8009269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient.
    Aruna AS; Murungi JH
    Ann Pharmacother; 2005 Jun; 39(6):1131-5. PubMed ID: 15840734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome in the intensive care unit.
    Sing RF; Branas CC; Marino PL
    J Am Osteopath Assoc; 1993 May; 93(5):615-8. PubMed ID: 8314724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemostatic evaluation of a patient with haloperidol-induced neuroleptic malignant syndrome associated with disseminated intravascular coagulation].
    Seki Y; Takahashi H; Aizawa Y
    Rinsho Ketsueki; 1998 May; 39(5):374-8. PubMed ID: 9637888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroleptic malignant syndrome, multiorgan failure and peripheral polyneuropathy].
    Mesejo A; Núñez C; Simó M; Blanquer J; Pérez PL; Ruiz F; Cuñat J
    Rev Neurol; 1995; 23(119):136-8. PubMed ID: 8548608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
    Mendhekar DN; Jiloha RC
    Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023
    [No Abstract]   [Full Text] [Related]  

  • 12. [Malignant neuroleptic syndrome associated with myocardial infarction, acute renal insufficiency and rhabdomyolysis].
    Benatar Haserfaty J; García Pérez del Río J; Román Tabernero M; Durán Insúa F; Ascorve Domínguez A
    Rev Esp Anestesiol Reanim; 1991; 38(4):261-4. PubMed ID: 1685257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroleptic malignant syndrome].
    Charra B; Nejmi H; Hachimi A; Benslama A; Motaouakkil S
    Ann Fr Anesth Reanim; 2006 May; 25(5):542-3. PubMed ID: 16488105
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acute renal failure in neuroleptic malignant syndrome].
    Wagner G; Rónai L
    Orv Hetil; 1995 Oct; 136(40):2173-6. PubMed ID: 7566952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infections as complications of neuroleptic malignant syndrome.
    Bilanakis N; Peritogiannis V; Kalampokis G
    World J Biol Psychiatry; 2009; 10(4 Pt 3):973-6. PubMed ID: 18609425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome and clozapine withdrawal at the same time?
    Margetić B; Aukst-Margetić B
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):145-7. PubMed ID: 15610957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
    World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic malignant syndrome: three episodes with different drugs.
    Lavie CJ; Ventura HO; Walker G
    South Med J; 1986 Dec; 79(12):1571-3. PubMed ID: 2878496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic malignant syndrome: an experience of four cases.
    Desai ND; Mundra VK; Gore YS; Diwan PJ; Jaydeokar SS; Jain V; Sutharsan R; Agarwal A; Moulick ND; Manocha SM
    J Assoc Physicians India; 1998 Jul; 46(7):653-4. PubMed ID: 12152854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The application of electroconvulsive therapy in neuroleptic malignant syndrome treatment in patient with catatonic schizophrenia].
    Kucia K; Warchala A
    Wiad Lek; 2005; 58(9-10):572-4. PubMed ID: 16529073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.